French medical staff refused to receive AstraZeneca vaccine has a large number of adverse reactions-Shangbao Indonesia

[Overseas Network]Since February 6, France has listed the vaccine jointly developed by the University of Oxford and AstraZeneca Pharmaceutical Group as the preferred choice for health professionals under 65. However, French medical staff would rather wait than get the vaccine immediately.
According to France’s BFM TV station, French Minister of Health Olivier Vérin took the lead in vaccinating the Oxford/AstraZeneca vaccine on the 8th. However, because this vaccine is less effective against the new strain of the new coronavirus discovered in South Africa, and its possible side effects are dubious, French health professionals are very resistant to this vaccine and would rather spend time waiting for other vaccines.
The French medical community is generally concerned about two problems with the Oxford/AstraZeneca vaccine. First, it is currently uncertain whether the vaccine is effective against the new strains discovered in South Africa and Brazil. Although this vaccine is cheaper and easier to store, its effectiveness is only 60% to 70%, and its effectiveness against certain new strains may drop to 50% or even less than 25%. Therefore, the South African government has stopped the Oxford/AstraZeneca vaccination campaign. In France, the spread of new strains of the new coronavirus is accelerating, and people are reluctant to choose vaccines with uncertain efficacy.
On the other hand, the French National Agency for the Safety of Medicines (ANSM) issued a warning on the 11th of this month, stating that 149 out of 10,000 people who received the first dose of the Oxford/AstraZeneca vaccine in the morning from the 6th to the 10th When a very serious adverse reaction occurs, including sudden high fever, headache, body pain, etc., it mainly affects health professionals with an average age of 34. Some hospitals in France, especially those in Brittany, have been forced to adjust their vaccination plans to avoid staff taking sick leave after being vaccinated, resulting in a shortage of medical staff. In Brest, Brittany, 20% to 25% of medical staff who received the vaccine stopped working due to adverse reactions.
The French province of Moselle is being seriously affected by the new strains discovered in South Africa and Brazil. Monique François, the representative of the health industry union in the province, said that the province of Moselle has received another 2,000 doses of Pfizer and Modena from the United States. Vaccines, “Many people would rather not get the vaccine than the AstraZeneca vaccine.”
French epidemiologist Benjamin Davido pointed out in an interview with The Echo that “it is unacceptable to vaccinate health care workers with a vaccine that may be less effective. The virus is still spreading widely. The staff are all sick and there is no staff to continue to provide services to the patients.” He added that he himself did not want to receive the Oxford/AstraZeneca vaccine and would rather continue to wait. A doctor at the Necker Children’s Hospital in Paris said that some medical staff were notified that they could receive the Oxford/AstraZeneca vaccine, but due to a lack of people willing to vaccinate, the program was stopped a day later.
Emmanuel Loeb, chairman of the French Young Doctors Union, expressed the hope that the Ministry of Health can hold a meeting with representatives of health professionals to negotiate, or reassure everyone, or propose another vaccine option. On the 15th, Jerome Marty, chairman of the French Free Doctors Union, called on BFM television, “Do not use the Oxford/AstraZeneca vaccine for medical staff, but should be used to vaccinate healthy, low-risk young people. We need medical staff. Continue to work, this is a balance between benefits and risks.” He also emphasized that the Oxford/AstraZeneca vaccine is “ineffective against the new strain found in South Africa”, and medical staff will inevitably be exposed to this new strain of infection at work. By.

– .